WHO Announces First Prequalification for Tuberculosis Test
WHO granted prequalification to a tuberculosis molecular diagnostic test that delivers rapid detection of TB and drug resistance.
Category: Tuberculosis
Tuberculosis
Latest
Tuberculosis
Latest
Actiphage Could Provide ‘Test of Cure’ for New TB Drugs
Actiphage has the potential to provide a reliable test of cure for new tuberculosis drugs, according to recent research.
Tuberculosis
Latest
PerkinElmer Completes Acquisition of Latent TB Diagnostics Specialist
Oxford Immunotec is recognized as a global leader of proprietary test kits for latent tuberculosis. known for its T-SPOT.TB test.
Lophius Biosciences Closes $3.4 Million Financing Round for TB Detection Assay
The funding will enable Lophius to expand clinical performance data and finalize design of the assay for use on automated platforms.
Read MoreGNA Biosolutions Closes $13.5 Million Financing Round Backed by US and EU Consortium
Series C funding will finance further development and CE marking of the company’s first molecular point-of-care platform based on pulse-controlled amplification technology.
Read More
Roche Expands Global Access Program to Include Diagnostics for Hepatitis, Human Papillomavirus, and Tuberculosis
Access to innovative diagnostic solutions will contribute to the World Health Organization’s infectious disease elimination goals.
Read More
Researchers Discover Causative Genetic Mutations in Patients with Familial Sarcoidosis
Study data show that the metabolic sensor mTOR contributes on the genetic level to the development of sarcoidosis.
Read More
Study Results Guide Anti-CMV Treatment after Stem Cell Transplantation
Continued validation of Lophius’ development capabilities bodes well as the company advances into tuberculosis diagnostics as its next focus area.
Read More
BD Launches Molecular Test for Tuberculosis
The BD Max MDR-TB panel has obtained the CE mark, supporting market launch in Europe.
Read More
Advancing Tuberculosis Testing
Protecting sample stability ensures the utility of the latest generation of TB tests.
Read More
TB Data-Sharing Platform Launches to Public
The analytic visualization tool can be used to discover, grade, and track key bacterial drug-resistance mutations.
Read More
Study Confirms Blood Test as Predictor of Tuberculosis Risk
The landmark NIH study represents a major advance in tuberculosis research.
Read MoreUSAID, Cepheid Join Forces to Battle Multidrug-Resistant Tuberculosis
Cepheid has signed a memorandum of understanding representing its intention to work with USAID to support the White House’s national action plan for combating MDR-TB.
Read More
Critical Path Institute Receives Grant 
to Accelerate Tuberculosis Diagnostics
A multiyear grant from the Bill & Melinda Gates Foundation will fund an innovative global data platform
 designed to streamline tuberculosis diagnosis and treatment.
Read More
FDA Approves Cepheid’s Rapid TB Test
Results are available to clinicians in approximately 2 hours.
Read More
NanoLogix Rapid TB Detection Results Published In Journal
Third-party R&D lab achieves 5-day tuberculosis detection, compared to weeks for standard tests.
Read MoreNEJM Reports Xpert MTB/RIF Faster, Sensitive & Specific Test for TB
Cepheid announced that its Xpert MTB/RIF test was the subject of a study published in the latest edition of the New England Journal of Medicine (NEJM), “Rapid Molecular Detection of Tuberculosis and Rifampin Resistance.”
Read MoreNew Blood-Based Genomic Marker for Tuberculosis May Help ID Future Patients
It may soon be possible to identify patients who will develop tuberculosis, as scientists have identified changes in the blood specific to the disease.
Read More